Derapi | $7,000,000 | (Feb 4, 2026)
Naoma AI | $440,000 | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)
Certified by Founder
Lodge
Ability Biologics
start up
Canada
- Montreal, Quebec
- 07/12/2023
- Seed
- $12,000,000
Our Mission:
Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.
The premier biotherapeutic targeting company
Our powerful AbiLeap™ discovery engine combines massively parallel, continuously learning AI with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies of exquisite selectivity and affinity. The antibodies respond to environmental signals within the cellular microenvironment, generating logic-gated therapeutics.
We are dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need.
- Industry Biotechnology Research
- Website https://ability.bio/
- LinkedIn https://www.linkedin.com/company/ability-biologics/about/
OneDome | $25,000,000 | (Feb 4, 2026)
ecovia I bio | Undisclosed Amount | (Feb 4, 2026)
AIRRIVED | $6,100,000 | (Feb 4, 2026)
MaiaEdge | $20,000,000 | (Feb 4, 2026)
Mitra EV | $27,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
Graici | $7,500,000 | (Feb 4, 2026)
Linq | $20,000,000 | (Feb 3, 2026)
Breezy | $10,000,000 | (Feb 3, 2026)